Full Text
The Full Text of this article is available as a PDF (1.3 MB).
. 2006 Jul 1;6(4):356–359. doi: 10.7861/clinmedicine.6-4-356
Current clinical uses of intravenous immunoglobulin
T El-Shanawany
1, WAC Sewell
2, SA Misbah
3, Stephen Jolles
4
T El-Shanawany, MRCP
1University Hospital of Wales, Cardiff
Specialist Registrar in Immunology
Find articles by T El-Shanawany
WAC Sewell, PhD FRCP MRCPath
2University of Lincoln, Lincoln
Visiting Professor of Immunology
Find articles by WAC Sewell
SA Misbah, FRCP FRCPath
3Churchill Hospital, Oxford
Consultant Immunologist
Find articles by SA Misbah
Stephen Jolles, PhD MRCP MRCPath
4University Hospital of Wales, Cardiff
Consultant Immunologist and Allergist
Find articles by Stephen Jolles
1University Hospital of Wales, Cardiff
2University of Lincoln, Lincoln
3Churchill Hospital, Oxford
4University Hospital of Wales, Cardiff
Roles
T El-Shanawany: MRCP, Specialist Registrar in Immunology
WAC Sewell: PhD FRCP MRCPath, Visiting Professor of Immunology
SA Misbah: FRCP FRCPath, Consultant Immunologist
Stephen Jolles: PhD MRCP MRCPath, Consultant Immunologist and Allergist
Key Words: blistering diseases, chronic inflammatory demyelinating polyneuropathy, hypogammaglobulinaemia, immunomodulation, intravenous immunoglobulin
© 2006 Royal College of Physicians
PMCID: PMC4953515 PMID: 16956140